Javascript must be enabled to continue!
Ellagic Acid Potentiates the Inhibitory Effects of Fluconazole Against Candida albicans
View through CrossRef
Background/Objectives: Antifungal resistance to azoles, coupled with the increasing prevalence of Candida albicans infections, represents a significant public health challenge and has driven the search for new natural compounds that can act as alternatives or adjuvants to the current antifungals. Ellagic acid (EA) has demonstrated antifungal activity; however, its effects are not fully understood. In this study, we investigated the in vitro anti-Candida activity of EA and its ability to potentiate the effects of fluconazole (FLZ) on C. albicans. Methods: The Minimum Inhibitory Concentration (MIC) of EA was determined by broth microdilution and its interaction with FLZ was assessed using a checkerboard assay. Additionally, we examined the effects of EA on yeast-to-hypha transition, inhibition of biofilm formation, time–kill kinetics, hemolytic activity, and cytotoxicity in HeLa ATCC® CCL-2™ cells. Results: EA exhibited MIC values ranging from 250 to 2000 µg/mL and showed synergistic and additive interactions with FLZ, resulting in a marked reduction in the MIC values of FLZ (up to 32-fold) and EA (up to 16-fold). In the time–kill assay, the most effective combinations were 4× EA MIC, 2× EA MIC, and FIC EA + FLZ, which showed fungicidal activity. Furthermore, EA did not show hemolytic activity and demonstrated low and dose-dependent cytotoxicity in HeLa cells, with no cytotoxic effects observed in combination with FLZ. EA and the synergistic combination of EA and FLZ interfered with both the yeast-to-hypha transition process in C. albicans cells and biofilm formation. In addition to its antifungal efficacy, EA demonstrated a favorable safety profile at the concentrations used. Conclusions: This study presents promising results regarding the potential use of EA in combination with FLZ for the treatment of C. albicans infections.
MDPI AG
Amanda Graziela Gonçalves Mendes
Carmem Duarte Lima Campos
José Lima Pereira-Filho
Aleania Polassa Almeida Pereira
Gabriel Silva Abrantes Reis
Árlon Wendel de Marinho Silva Araújo
Pablo de Matos Monteiro
Flávia Castello Branco Vidal
Silvio Gomes Monteiro
Isabella Fernandes da Silva Figueiredo
Elizabeth Soares Fernandes
Cristina de Andrade Monteiro
Valério Monteiro-Neto
Title: Ellagic Acid Potentiates the Inhibitory Effects of Fluconazole Against Candida albicans
Description:
Background/Objectives: Antifungal resistance to azoles, coupled with the increasing prevalence of Candida albicans infections, represents a significant public health challenge and has driven the search for new natural compounds that can act as alternatives or adjuvants to the current antifungals.
Ellagic acid (EA) has demonstrated antifungal activity; however, its effects are not fully understood.
In this study, we investigated the in vitro anti-Candida activity of EA and its ability to potentiate the effects of fluconazole (FLZ) on C.
albicans.
Methods: The Minimum Inhibitory Concentration (MIC) of EA was determined by broth microdilution and its interaction with FLZ was assessed using a checkerboard assay.
Additionally, we examined the effects of EA on yeast-to-hypha transition, inhibition of biofilm formation, time–kill kinetics, hemolytic activity, and cytotoxicity in HeLa ATCC® CCL-2™ cells.
Results: EA exhibited MIC values ranging from 250 to 2000 µg/mL and showed synergistic and additive interactions with FLZ, resulting in a marked reduction in the MIC values of FLZ (up to 32-fold) and EA (up to 16-fold).
In the time–kill assay, the most effective combinations were 4× EA MIC, 2× EA MIC, and FIC EA + FLZ, which showed fungicidal activity.
Furthermore, EA did not show hemolytic activity and demonstrated low and dose-dependent cytotoxicity in HeLa cells, with no cytotoxic effects observed in combination with FLZ.
EA and the synergistic combination of EA and FLZ interfered with both the yeast-to-hypha transition process in C.
albicans cells and biofilm formation.
In addition to its antifungal efficacy, EA demonstrated a favorable safety profile at the concentrations used.
Conclusions: This study presents promising results regarding the potential use of EA in combination with FLZ for the treatment of C.
albicans infections.
Related Results
Hefebefunde bei Reihenuntersuchungen an Soldaten der Bundeswehr
Hefebefunde bei Reihenuntersuchungen an Soldaten der Bundeswehr
ZusammenfassungBei Reihenuntersuchungen an 1325 Soldaten wurde die Sproßpilzbesiedlung der Mund‐böhle (1325 Abstriche), der Analregion (949 Abstriche), des Penis (1325 Abklatsch‐Ku...
Synergistic Interactions between Pseudomonas aeruginosa and Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis as well as Candida tropicalis in the Formation of Polymicrobial Biofilms
Synergistic Interactions between Pseudomonas aeruginosa and Candida albicans, Candida glabrata, Candida krusei, Candida parapsilosis as well as Candida tropicalis in the Formation of Polymicrobial Biofilms
The interactions between pathogens during infection and the impact of these interactions on drug effectiveness are poorly understood, making polymicrobial infections challenging to...
In vitro susceptibility testing of Candida species isolated from blood stream infections to five conventional antifungal drugs
In vitro susceptibility testing of Candida species isolated from blood stream infections to five conventional antifungal drugs
Candida is an opportunistic fungal pathogen which can cause fatal bloodstream infections (BSIs) in immunocompromised and immunodeficient persons. In this study, the susceptibility ...
Species Distribution and Antifungal Susceptibility Pattern of Candida Isolates Causing Neonatal Sepsis in a Tertiary-Care NICU
Species Distribution and Antifungal Susceptibility Pattern of Candida Isolates Causing Neonatal Sepsis in a Tertiary-Care NICU
Background: A global shift from Candida albicans to non-albicans candida (NAC) species has been reported in neonatal
candidemia, with important implications for empirical antifung...
Simultaneous quantitative estimation of ellagic acid and gallic acid in Sudanese Solanum dubium seed by high performance thin layer chromatography (HPTLC)
Simultaneous quantitative estimation of ellagic acid and gallic acid in Sudanese Solanum dubium seed by high performance thin layer chromatography (HPTLC)
Background: Solanum dubium is a plant believed to have several therapeutic effects including anti-asthmatic properties. The objective of this study was to investigate the quantitat...
Prevalence of Candidemia with Susceptibility Pattern in a Tertiary Care Hospital in North India
Prevalence of Candidemia with Susceptibility Pattern in a Tertiary Care Hospital in North India
BACKGROUND Blood stream infections (BSI) caused by various candida species have been reported from many countries worldwide and are a significant cause of morbidity and mortality i...
Evaluation of antifungal activity of lactic acid bacteria from locally sourced yoghurts on isolates of <i>Candida Albicans</i> from cases of vaginitis
Evaluation of antifungal activity of lactic acid bacteria from locally sourced yoghurts on isolates of <i>Candida Albicans</i> from cases of vaginitis
This study assessed antifungal activity of lactic acid bacteria from locally made yoghurts on isolates of candida albicans from cases of vaginitis. Locally sourced yoghurt samples...
Enhancing the Antifungal Efficacy of Fluconazole with a Diterpene: Abietic Acid as a Promising Adjuvant to Combat Antifungal Resistance in Candida spp.
Enhancing the Antifungal Efficacy of Fluconazole with a Diterpene: Abietic Acid as a Promising Adjuvant to Combat Antifungal Resistance in Candida spp.
The increasing antifungal resistance rates against conventional drugs reveal the urgent need to search for new therapeutic alternatives. In this context, natural bioactive compound...

